EXCELSIOR BIOPHARMA INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.3 TWD | +0.89% |
|
+0.89% | -1.91% |
| Sales 2022 | 672M 20.75M | Sales 2023 | 772M 23.84M | Capitalization | 1.36B 41.9M |
|---|---|---|---|---|---|
| Net income 2022 | -33M -1.02M | Net income 2023 | -91M -2.81M | EV / Sales 2022 | 0.81 x |
| Net cash position 2022 | 755M 23.33M | Net cash position 2023 | 236M 7.28M | EV / Sales 2023 | 1.45 x |
| P/E ratio 2022 |
-37.6
x | P/E ratio 2023 |
-14.6
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 38.76% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.89% | ||
| 1 week | +0.89% | ||
| Current month | +0.89% | ||
| 1 month | +0.71% | ||
| 3 months | +1.62% | ||
| 6 months | +0.18% | ||
| Current year | -1.91% |
1 week
27.75
28.45
1 month
27.0028.60
Current year
27.0029.65
1 year
27.0036.30
3 years
25.8036.45
5 years
22.2553.00
10 years
22.25151.45
| Managers | Title | Age | Since |
|---|---|---|---|
Tse Min Chen
CEO | Chief Executive Officer | - | 88-07-20 |
Ming Tse Chen
DFI | Director of Finance/CFO | - | - |
Hui Chen Liu
ADM | Chief Administrative Officer | - | 12-11-03 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Hsiu Hui Li
BRD | Director/Board Member | - | 12-11-03 |
Man Hsiang Li
BRD | Director/Board Member | - | 12-11-03 |
Hsi Chieh Wang
BRD | Director/Board Member | - | 12-11-03 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 28.3 | +0.89% | 15,020 |
| 24-04-17 | 28.05 | +0.18% | 7,547 |
| 24-04-16 | 28 | -0.18% | 21,000 |
| 24-04-15 | 28.05 | +0.18% | 36,123 |
| 24-04-12 | 28 | -0.18% | 15,542 |
End-of-day quote Taipei Exchange, April 17, 2024
More quotes
Excelsior Biopharma Inc. is a Taiwan-based company principally engaged in the research, development, production and sales of prescription drugs. The Company's main products include prescription drugs, non-prescription drugs, health care products, medical equipment and rapid test reagents. The Company distributes its product in domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -1.91% | 40.57M | |
| +27.97% | 676B | |
| +23.58% | 554B | |
| -7.02% | 349B | |
| +14.85% | 318B | |
| +6.25% | 291B | |
| +2.96% | 210B | |
| -0.41% | 204B | |
| -10.02% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- 6496 Stock
